Search

  • HOME
  • Search
Clinical Predictors of ARTA Response in Metastatic Prostate Cancer
Original Article
561
Negative Delta-Prostate-Specific Antigen Time Ratio as Potential New Marker of Progression-Free Survival in Castration-Resistant Prostate Cancer Patients Treated With First-Line Enzalutamide or Docetaxel
Tae Hwan Kim, Seol Ho Choo, Kang Hee Shim, Sun Il Kim
Journal of Urologic Oncology. 2023;21(3):271-276.   Published online November 30, 2023
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Review Article
The Current Status of Metastatic Castration-Naïve Prostate Cancer Management
See Min Choi, Jae Hwi Choi, Jeong Seok Hwa
Korean J Urol Oncol. 2020;18(1):11-17.   Published online April 29, 2020
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Original Article
374
Clinical Outcomes of Continuous Addition of Androgen Deprivation Therapy During Docetaxel Chemotherapy for Patients With Castration-Resistant Prostate Cancer
Dong Hoon Lee, Jung Ho Kim, Won Ik Seo, Jong Kil Nam, Tae Nam Kim, Cheol Kyu Oh, Soo Dong Kim, Sung-Woo Park, Jae Sung Chung, Sang Hyun Park, Wan Lee, Gyung Tak Sung, Moon Kee Chung, Jae Il Chung
Korean J Urol Oncol. 2017;15(2):59-65.   Published online August 29, 2017
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    

Journal of
Urologic Oncology

Print ISSN: 2951-603X
Online ISSN: 2982-7043



Editorial Office
Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817,   FAX: +82-2-742-4665   Email: journal@e-juo.org
Korean Urological Oncology Society
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-704-8574, E-mail: kspe.editor@gmail.com

Copyright © The Korean Urological Oncology Society.

Developed in M2PI